Tag: Mercator MedSystems
Mercator announces completion of enrolment in LIMBO-ATX
Mercator MedSystems has announced completion of enrolment in the company’s LIMBO-ATX (Lower-limb adventitial infusion of dexamethasone via Bullfrog to reduce occurrence of restenosis after...
First patients enrolled in Mercator MedSystems TANGO trial
Mercator MedSystems has announced the first patient enrolment into the TANGO (Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee) clinical trial. TANGO...
Mercator MedSystems’ DANCE trial shows positive results for Bullfrog micro-infusion device...
Mahmood Razavi and George Adams, the national co-principal unvestigators of Mercator MedSystem's DANCE trial, have each presented comprehensive 13-month data from the trial during...
Positive late-breaking DANCE clinical trial data presented at VIVA 2016
Christopher Owens, associate professor of Surgery in the Division of Vascular and Endovascular Surgery at the University of California, San Francisco (UCSF), USA, has...
